GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taro Pharmaceutical Industries Ltd (NYSE:TARO) » Definitions » Insider Ownership

Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Insider Ownership : 6.74 % (As of Apr. 28, 2024)


View and export this data going back to 1987. Start your Free Trial

What is Taro Pharmaceutical Industries Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Taro Pharmaceutical Industries's insider ownership is 6.74%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Taro Pharmaceutical Industries's Institutional Ownership is 6.82%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Taro Pharmaceutical Industries's Float Percentage Of Total Shares Outstanding is 21.52%.


Taro Pharmaceutical Industries Insider Ownership Historical Data

The historical data trend for Taro Pharmaceutical Industries's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taro Pharmaceutical Industries Insider Ownership Chart

Taro Pharmaceutical Industries Historical Data

The historical data trend for Taro Pharmaceutical Industries can be seen below:

2007-12-31 2008-01-31 2008-02-29 2008-03-31
Insider Ownership 8.29 6.74 6.74 6.74

Taro Pharmaceutical Industries Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Business Description

Traded in Other Exchanges
Address
14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
Executives
Sun Pharma Global Inc 10 percent owner
Sun Pharmaceutical Industries Ltd 10 percent owner, other: Affiliated Party 17/B, MAHAL INDUSTRIAL ESTATE, MAHAKALI CAVES ROAD, ANDEHERI (EAST) K7 400 093
Alkaloida Chemical Co Exclusive Group Ltd. 10 percent owner KABAY JANOS UT 29., TISZAVASVARI K5 4440
Franklin Resources Inc 10 percent owner FRANKLIN RESOURCES INC, ONE FRANKLIN PARKWAY, SAN MATEO CA 94403

Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Headlines

From GuruFocus

Taro to Announce First Quarter Results on July 27, 2021

By Business Wire Business Wire 07-21-2021

Taro Appoints New Chief Financial Officer

By Business Wire Business Wire 12-01-2021

Taro to Announce Full Year Results on May 19, 2021

By Business Wire Business Wire 05-12-2021

Taro Completes Acquisition of Alchemee

By Business Wire Business Wire 03-01-2022

Taro to Announce Full Year Results on May 26, 2022

By Business Wire Business Wire 05-21-2022

Taro to Release First Quarter Results on July 27, 2022

By Business Wire Business Wire 07-26-2022